2-chloro-n(6)cyclopentyladenosine has been researched along with mrs 1220 in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (mrs 1220) | Trials (mrs 1220) | Recent Studies (post-2010) (mrs 1220) |
---|---|---|---|---|---|
252 | 0 | 43 | 54 | 1 | 13 |
Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | mrs 1220 (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 0.0036 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0479 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barak, D; Biadatti, T; Chen, W; Gao, ZG; Jacobson, KA; Johnson, CR; Kim, SG; Kim, SK; Lee, K | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and mrs 1220
Article | Year |
---|---|
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Topics: Adenosine; Animals; Binding, Competitive; CHO Cells; Cricetinae; Epoxy Compounds; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Models, Molecular; Mutation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Ribose; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship | 2002 |